Share
Market Research Report

HUMAN-RELEVANT DRUG SAFETY TESTING SERVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Service TypeToxicity Testing Services · Organ-Specific Safety Assessment Services · Genotoxicity and Mutagenicity Testing Services · Safety Pharmacology Services. Model Validation and Regulatory Support Services
  • By Model TypeHuman Cell-Based Models · 3D Cell Culture Models and Organoids · Organ-on-Chip Models · Human Tissue-Based Models · Computational and In-Silico Models
  • By Therapeutic AreaOncology · Neurological Disorders · Cardiovascular Diseases · Metabolic and Liver Diseases · Infectious Diseases · Others
  • By ApplicationDrug Discovery and Development · Preclinical Toxicity Assessment · Drug-Induced Organ Toxicity Testing · Biologics and Advanced Therapy Safety Testing · Regulatory Safety Assessment · Others
  • By End UserPharmaceutical and Biotechnology Companies · Contract Research Organizations (CROs) · Academic and Research Institutions · Medical Device and Diagnostics Companies · Others
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East · and Africa
  • Published In02 Nov 2026
  • Report CodeCMI10330
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Human-Relevant Drug Safety Testing Services Market, By Service Type
      • Global Human-Relevant Drug Safety Testing Services Market, By Model Type
      • Global Human-Relevant Drug Safety Testing Services Market, By Therapeutic Area
      • Global Human-Relevant Drug Safety Testing Services Market, By Application
      • Global Human-Relevant Drug Safety Testing Services Market, By End User
      • Global Human-Relevant Drug Safety Testing Services Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Industry Trends
  4. Global Human-Relevant Drug Safety Testing Services Market, By Service Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Toxicity Testing Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Organ-Specific Safety Assessment Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Genotoxicity and Mutagenicity Testing Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Safety Pharmacology Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Model Validation and Regulatory Support Services
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  5. Global Human-Relevant Drug Safety Testing Services Market, By Model Type, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Human Cell-Based Models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • 3D Cell Culture Models and Organoids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Organ-on-Chip Models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Human Tissue-Based Models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Computational and In-Silico Models
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  6. Global Human-Relevant Drug Safety Testing Services Market, By Therapeutic Area, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Neurological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Cardiovascular Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Metabolic and Liver Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  7. Global Human-Relevant Drug Safety Testing Services Market, By Application, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Drug Discovery and Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Preclinical Toxicity Assessment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Drug-Induced Organ Toxicity Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Biologics and Advanced Therapy Safety Testing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Regulatory Safety Assessment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  8. Global Human-Relevant Drug Safety Testing Services Market, By End User, 2021-2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pharmaceutical and Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Contract Research Organizations (CROs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Academic and Research Institutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Medical Device and Diagnostics Developers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  9. Global Human-Relevant Drug Safety Testing Services Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Service Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Model Type, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  10. Competitive Landscape

    • Charles River Laboratories International, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Eurofins Scientific SE
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Labcorp
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • WuXi AppTec Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • REPROCELL Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Emulate, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Genoskin
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Alcyomics Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • InSphero AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • MIMETAS B.V.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology

    • References
    • Research Methodology
    • About us

Browse 32 market data tables and 28 figures on Human-Relevant Drug Safety Testing Services Market' - Global forecast to 2033